Continue Reading... Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?
Posted in Cannabis Stocks

Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?

Although cannabis stocks have not performed well over the past five years, there is still some hope left for the…

Continue Reading... Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled
Posted in Cannabis Stocks

Why Tilray’s Marijuana Rescheduling Sizzle Has Fizzled

Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin,…

Continue Reading... Cannabis ETFs: Regulatory Momentum Returns Focus
Posted in Cannabis Stocks

Cannabis ETFs: Regulatory Momentum Returns Focus

Cannabis stocks often trade less on traditional fundamentals alone and more on changes in policy. Cannabis ETFs are a narrow…

Continue Reading... Forget SNDL: HITI is a Significantly Better Cannabis Stock
Posted in Cannabis Stocks

Forget SNDL: HITI is a Significantly Better Cannabis Stock

Every cannabis trader’s feed is buzzing about SNDL (NASDAQ:SNDL) because the company’s Q1 2026 release on April 28, 2026 delivered…

Continue Reading... Prediction: Green Thumb Industries Stock Will Double Within 3 Years
Posted in Cannabis Stocks

Prediction: Green Thumb Industries Stock Will Double Within 3 Years

Green Thumb is about as blue chip as it comes in the U.S. cannabis industry. The company has multiple potential…

Continue Reading... Aurora Cannabis: Why I Like This Stock
Posted in Cannabis Stocks

Aurora Cannabis: Why I Like This Stock

Aurora Cannabis Inc. outlook: improving international revenue, margins, and net cash. Valuation suggests 64% upside to $5.58. Click for more…

Continue Reading... The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Posted in Cannabis Stocks

The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off

Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved and state-licensed medical…

Continue Reading... Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.
Posted in Cannabis Stocks

Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.

Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug…

Continue Reading... Cannabis Stocks Jump After U.S. Reclassifies Marijuana as Less Dangerous Drug
Posted in Cannabis Stocks

Cannabis Stocks Jump After U.S. Reclassifies Marijuana as Less Dangerous Drug

Shares of cannabis companies rose after the Trump administration reclassified marijuana as a less dangerous drug. Curaleaf increased 5.8% in…

Continue Reading... Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
Posted in Cannabis Stocks

Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis

The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive…